What is the estimated price of mobosetinib/mobobotinib in 2025

Mobocertinib is a targeted therapy drug mainly used to treat epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) . The drug achieves anti-tumor effects by selectively inhibiting the mutated form of EGFR and blocking the proliferation signals of tumor cells. Mobosetinib is particularly suitable for patients who are resistant to traditional chemotherapy or other targeted drugs, providing a new treatment option.

In China, the original drug of moboxetinib has been officially launched, but due to changes in market policies and medical insurance, the specific price and medical insurance reimbursement information are still unclear. This leaves patients facing a certain lack of information when choosing medications. In addition, in some specific regions, such as certain international markets, the selling price of the clinical version of mobotinib has been disclosed. Taking medicine of 40 mg size and 30 pills per box as an example, its price is about more than 7,000 yuan. It is worth noting that this price will be affected by the exchange rate, so it may fluctuate.

At the same time, there are also generic drugs of Mobotinib available in overseas markets. Usually, the ingredients of these generic drugs are basically the same as those of the original drug, ensuring the therapeutic effect. For example, the 40mg*120-tablet version of Mobotinib produced by a pharmaceutical factory in Laos may cost only more than 4,000 yuan, which has a clear price advantage over the original drug. However, it's also important to note that the price of generic drugs is also affected by exchange rate movements, so the actual amount paid may vary.

Although the price of mobosetinib is relatively high in some markets, its efficacy in the treatment of non-small cell lung cancer makes many patients willing to bear this cost. When choosing medications, patients should fully communicate with their attending doctors and comprehensively consider their own condition, financial situation, and the effectiveness and safety of the medication.

Reference materials:https://en.wikipedia.org/wiki/Mobocertinib